Acerus Pharmaceuticals
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
7025 Langer Dr Ste 205, Mississauga, Ont...Phone Number
+55 4164649949Website
www.aceruspharma.comRevenue
<$5 MillionStock Symbol
ASPIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin analog indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least 2 times per night to void. It also engages in developing Lidbree, a short acting lidocaine formulation delivered through a proprietary device into the vaginal mucosal tissue; Stendra, a PDE5 inhibitor for the treatment of erectile dysfunction; Tefina, a clinical stage product for women with female sexual dysfunction; and Noctiva combination products, which are in the pre-clinical development stage for the treatment of benign prostatic hypertrophy, overactive bladder, and pediatric nocturnal enuresis. In addition, the company provides TriVair tecRead more
Acerus Pharmaceuticals Org Chart
SE
Pharmaceutical Development Senior Director, T...
Jd
Director, Marketing (US)
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acerus Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Acerus Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Acerus Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at Acerus Pharmaceuticals
Website visits: Recent activity has been detected on your website
Click to see if Acerus Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Acerus Pharmaceuticals launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Acerus Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Acerus Pharmaceuticals recently announced quarterly report
Acerus Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Acerus Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Acerus Pharmaceuticals
Compare insights from companies similar to Acerus Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Acerus Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Acerus Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Acerus Pharmaceuticals.
Acerus Pharmaceuticals financials insights
Gather financial insights about Acerus Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Debt
$6.5M
2020
Share Placement
$18M
Acerus Pharmaceuticals Tech Stack
A closer look at the technologies used by Acerus Pharmaceuticals
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
Acerus Pharmaceuticals has announced that Kevin Hickey, Senior Vice President, Commercial (US), has left the organization to join Cosette Pharmaceuticals as Vice President, Brand Sales & Marketing.
Left Company
Executive Move
Left Company
Executive Move
Left Company
Executive Move
Acerus Pharmaceuticals News & Media
Acerus Announces Commencement of Court-Approved Sale and Investment Solicitation Process
TORONTO, March 14, 2023 (GLOBE NEWSWIRE) -- On January 26, 2023, Acerus Pharmaceuticals Corporation and certain of its subsidiaries (collectively, “Acerus”) were granted protection pursuant to an order (the “Initial Order”) issued under the Companies’ Creditors Arrangement Act (the “CCAA Proceedings”) by the Ontario Superior Court of Justice (the “Canadian Court”). Ernst & Young Inc. was appointed Monitor of Acerus (in such capacity, the “Monitor”). On February 3, 2023, the Initial Order was ameAcerus Files For CCAA Protection
TORONTO, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Acerus Pharmaceuticals Corporation (the “Company” or “Acerus”) (TSX: ASP; OTCQB: ASPCF) today announced that the Company and its subsidiaries, Acerus Biopharma Inc., Acerus Labs Inc. and Acerus Pharmaceuticals USA, LLC (collectively, the “Acerus Group”), have received an order for creditor protection (the “Initial Order”) from the Ontario Superior Court of Justice (Commercial List) (the “Court”) under the Companies’ Creditors Arrangement Act (the “CCAA”First Generation Capital Provides $2MM Senior Secured Loan to Acerus Pharmaceuticals
Acerus Pharmaceuticals announced that it and its wholly-owned subsidiary, Acerus Pharmaceuticals USA, LLC entered into a US$2 million secured loan agreement with First Generation Capital Inc., a company affiliated with the Chairman of the Board of Directors of Acerus. Funds under the Loan Agreement will be made available to the Borrowers by way of...Acerus Pharmaceuticals Corporation Announces Resignation of Scott Leckie from the Board ...
Acerus Pharmaceuticals Corporation announced that Mr. Scott Leckie has resigned from the board of directors of the Company, effective immediately.... | December 27, 2022
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Acerus Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; and Noctiva, a vasopressin anal... Read More
